December 10th & 11th, 2026
10th edition
MARSEILLE, FR

CardioRenal

Stand C5-B6

2023 Edition

CardioRenal

France

CardioRenal has developed the first in the world connected self-test allowing Heart Failure or Kidney disease patients to monitor their blood potassium at home as easily as diabetic patients measure their glycemia. The device, TENOR,  has been validated in a clinical study in Brussels. TENOR, is currently going through CE clinical trial and has been granted « breakthrough device label » by FDA.  Commercialisation in Europe will start in 2024.

Before you leave…

Download the official MedFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of MedFIT 2026.